Strategic Partnerships AUM Biosciences has recently formed strategic partnerships with companies like Handok Inc. and SPRIM Health Group. Leveraging these collaborations could open up avenues for cross-selling or upselling opportunities.

Series A Funding The successful completion of a $27 million Series A funding round indicates strong investor confidence in AUM Biosciences. This financial backing could be utilized to expand market reach and invest in sales initiatives.

Awards Recognition AUM Biosciences received the prestigious 2019 Asia-Pacific Biotech Entrepreneurial Company of the Year Award. Highlighting this accolade in sales pitches and communications can enhance the company's credibility and attract potential customers.

Precision Oncology Focus AUM Biosciences is dedicated to advancing a clinical pipeline of precision oncology therapeutics. Positioning these innovative therapies as cutting-edge solutions for cancer treatment could resonate well with healthcare providers and institutions seeking advanced treatment options.

Market Expansion AUM Biosciences has attracted significant investments and partnerships, indicating a potential for market expansion. Identifying new geographic regions or market segments for expansion based on the company's growth trajectory could lead to new sales opportunities.